Autophagy determines efficiency of liver-directed gene therapy with adeno-associated viral vectors-Reference-Cited by-同舟云学术

Autophagy determines efficiency of liver-directed gene therapy with adeno-associated viral vectors

Published:2017-05-29 Issue:1 Volume:66 Page:252-265
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Hösel Marianna¹²,Huber Anke¹²,Bohlen Susanne³,Lucifora Julie⁴,Ronzitti Giuseppe⁵,Puzzo Francesco⁵,Boisgerault Florence⁵,Hacker Ulrich T.⁶,Kwanten Wilhelmus J.⁷^ORCID,Klöting Nora⁸,Blüher Matthias⁹,Gluschko Alexander¹³,Schramm Michael¹³,Utermöhlen Olaf¹³,Bloch Wilhelm¹⁰,Mingozzi Federico⁵¹¹,Krut Oleg³,Büning Hildegard¹²¹²

Affiliation:

1. Center for Molecular Medicine Cologne (CMMC); University of Cologne; Cologne Germany

2. German Center for Infection Research (DZIF), Partner sites Bonn-Cologne and Hannover-Braunschweig; Germany

3. Institute for Medical Microbiology, Immunology and Hygiene; University of Cologne; Cologne Germany

4. INSERM, U1052, Cancer Research Center of Lyon (CRCL); University of Lyon; Lyon France

5. Genethon and INSERM U951; Evry France

6. University Medicine Leipzig; University Cancer Center Leipzig (UCCL); Leipzig Germany

7. Laboratory of Experimental Medicine and Pediatrics (LEMP); University of Antwerp; Antwerp Belgium

8. IFB Adiposity Diseases; University of Leipzig; Leipzig Germany

9. Department of Medicine; University of Leipzig; Leipzig Germany

10. Department of Molecular and Cellular Sport Medicine; German Sport University Cologne; Cologne Germany

11. University Pierre and Marie Curie; Paris France

12. Institute of Experimental Hematology, Hannover Medical School; Hannover Germany

Funder

German Research Foundation

Center for Molecular Medicine Cologne

Köln Fortune

European Research Council

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.29176/fullpdf

Reference43 articles.

1. Gene editing technology as an approach to the treatment of liver diseases;Aravalli;Expert Opin Biol Ther,2016

2. New and improved AAVenues: current status of hemophilia B gene therapy;Brimble;Expert Opin Biol Ther,2016

3. Engineering the AAV capsid to optimize vector-host interactions;Buning;Curr Opin Pharmacol,2015

4. Immune responses to AAV vectors: overcoming barriers to successful gene therapy;Mingozzi;Blood,2013

5. AAV-mediated gene therapy for liver diseases: the prime candidate for clinical application?;Laan;Expert Opin Biol Ther,2011

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adeno‐associated viral vector gene therapy: Challenges for the paediatric hepatologist;Journal of Pediatric Gastroenterology and Nutrition;2024-07-28

2. Role of FoxP3⁺ Regulatory T Cells in Modulating Immune Responses to Adeno-Associated Virus Gene Therapy;Human Gene Therapy;2024-07-01

3. Synergism of dual AAV gene therapy and rapamycin rescues GSDIII phenotype in muscle and liver;JCI Insight;2024-05-16

4. Absence of functional deficits in rats following systemic administration of an AAV9 vector despite moderate peripheral nerve and dorsal root ganglia findings: A clinically silent peripheral neuropathy;NeuroToxicology;2024-03

5. Non-canonical induction of autophagy increases adeno-associated virus type 2 (AAV2) transduction efficiency;2024-01-11